Uncategorized
BioLight announces positive study results for TeaRx
The TeaRx multi-assay test for evaluating tear components successfully completed its clinical study of both healthy subjects and patients suffering from dry eye syndrome, according to a press release from BioLight.The study was conducted by Ora and consisted of 74 enrolled subjects in the U.S. Four established benchmark tests for the assessment of dry eye syndrome (DES) were used to evaluate the subjects in an effort to define and distinguish healthy subjects from those with different grades of DES. The tests have previously been used by the FDA for the (Read more...)